CIK 0000025743
- Non-accelerated filer
- Smaller reporting company
TherapeuticsMD, Inc.
Sign in to watch- Ticker
- TXMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 870233535
- Phone
- +1 561-961-1900
- Business address
- 951 YAMATO ROAD, SUITE 220, BOCA RATON, FL, 33431
- Former names
- AMHN, Inc., CROFF ENTERPRISES INC, CROFF OIL CO
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-08-09 | Bernick Brian Director | Purchase | +10,000 | $2.87 | $29K | 62,000 |
| 2019-08-09 | Finizio Robert G CEO | Purchase | +52,405 | $2.96 | $155K | 18,218,964 |
| 2019-06-20 | Thompson Tommy G Director | Grant or award · Non-Qualified Stock Option (right to buy) | +112,500 | 112,500 | ||
| 2019-06-20 | SEGAL NICHOLAS Director | Grant or award · Non-Qualified Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2019-06-20 | Russell Angus C. Director | Grant or award · Non-Qualified Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2019-06-20 | MUSING JULES A. Director | Grant or award · Non-Qualified Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2019-06-20 | LaPenta Robert V Jr Director | Grant or award · Non-Qualified Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2019-06-20 | Collins Cooper C. Director | Grant or award · Non-Qualified Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2019-06-20 | CARROLL J MARTIN Director | Grant or award · Non-Qualified Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2019-06-20 | Barlow Jane F Director | Grant or award · Non-Qualified Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2019-05-13 | Collins Cooper C. Director | Purchase | +30,000 | $3.33 | $100K | 66,000 |
| 2019-05-13 | Thompson Tommy G Director | Purchase | +2,400 | $3.34 | $8K | 685,900 |
| 2019-02-28 | Finizio Robert G CEO | Gift | −200,000 | 18,166,559 | ||
| 2019-02-27 | MUSING JULES A. Director | Sale | −17,400 | $5.80 | $101K | 5,000 |
| 2018-12-20 | Finizio Robert G CEO | Exercise or conversion | +92,910 | $0.10 | $9K | 18,459,469 |
| 2018-12-20 | Finizio Robert G CEO | Sale | −92,910 | $3.63 | $337K | 18,366,559 |
| 2018-12-20 | Finizio Robert G CEO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −92,910 | 0 | ||
| 2018-12-19 | Finizio Robert G CEO | Exercise or conversion | +92,000 | $0.10 | $9K | 18,458,559 |
| 2018-12-19 | Finizio Robert G CEO | Sale | −92,000 | $3.70 | $340K | 18,366,559 |
| 2018-12-19 | Finizio Robert G CEO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −92,000 | 92,910 |
Page 15 of 24 · 463 trades